Engine Capital takes a stake in Avantor. Activist sees several ways to create value
Company: Avantor (AVTR)
Business: Avantor It is a global provider for critical products and services to life science tools company and life sciences and advanced technology industries. The company’s segments include laboratory solutions and biobilil production. It sells materials and consumables, equipment and instrumentation and services and special supplies to customers in biofarma and health services, education and government and advanced technologies and material industries. Materials and consumables include ultra -high purity chemicals and reagents, laboratory products and materials, highly specialized silicone materials, customized recipuals and others. Equipment and instrumentation filtration systems, virus inactivation systems, incubators, analytical instruments and others. Services and expertise include purchasing, laboratory and production, equipment, supply and supply and biofarmasalm material scaling and development services.
Stock market value: $ 8,85 billion ($ 12.98 per share)
Activist: Motor Capital
Ownership: ~ 3%
Average Cost: N/A
Activist Comment: Motor Capital is an experienced activist investor managed by manager Arnaud Ajdler. He is the former partner and senior general manager of Crescendo Partners. The history of the engine is to send letters and/or directors, but it is to settle quite quickly.
What’s going on
On August 11, the engine sent a letter to focus on commercial and operational excellence, showing organic growth, reducing costs, optimizing the portfolio, renewing the board and using a free cash flow for reimbursement stock. Motor, the company can take a sale as an alternative, he said.
Behind the curtain
Avantor is a market -leader distributor of Life Science tools and products for life sciences and advanced technology industries. The company consists of two segments: laboratory solutions (LSS) (67% of income) and biocimism production (BPS) (33% of income). LSS is one of the best living sciences distributors in the world (Termo Fisherman and Merck Kgaa the other two).
BPS is a supplier of high purity materials and is the leading supplier of medical class silicones. Although it was one of the several scale global life science tool distribution platforms, the company performed very low. On the 2021 Investor Day, the management envisaged earnings per share for 2025; And on the 2023 Investor Day, the management targeted a EBITDA margin exceeding 20%. Now in 2025, they are currently 96 cents per share and 11.8%. As a result, Avantor’s share price decreased by 53.96%, 59.69%and 43.41%in the last 1, 3 and 5 years in a statement on Monday.
The motor believes that Avantor’s significant miscarriage is the result of self -made mistakes based on a defective leadership team and frame. A complex matrix organizational structure and the lack of accountability made in the last three years, including the Avantor CEO, CFO and both segment leaders, have led to a mass leadership turnover and contributed to a dysfunctional decision -making process and inefficient structure.
The biggest wounded of this Rocky management team is LSS, who lost significant profitability and market share in its peers. In particular, the decisions of weak capital allocation have destroyed the important value. In 2020 and 2021, the Avantor spent a total of $ 3.8 billion to buy the Biography of Ritter, Masterflex and RIM, especially during the summit of Pandemi while the Life Sciences businesses were trading on extraordinary high floors. The application of Avantor to the average purchasing price of 28x 10 times more than the next 12 months means a loss value of over $ 2.4 billion in these purchases and contributes to the company’s high leverage.
Furthermore, despite the ongoing low performance of the LSS and strong leadership needs, it was left without a leader due to a non -competitive case from June 2024 to April 2025, which includes the recruitment of the new segment leader and underlined the operational dysfunction of the company.
However, perhaps the nail in the coffin for this management team and the board, despite this set of error and internal information of these predicted losses, was still given a way out. Company approached in 2023 INGERSOLL RAND The estimated per share will be obtained at $ 25-28, then the 20-35% premium of the stock price, but the Board rejected this approach in an undisclosed manner. Today, Avantor is traded slightly below $ 13 per share.
Enter the Motor, which describes a position of approximately 3% in Avantor and invites the Board to focus on commercial and operational excellence, show organic growth, reduce costs, optimize portfolio, renew the board, and use a free cash flow to reclaim its own stock.
The Motor shows that the Avantor’s $ 6.8 billion revenue is stretched in 6 million stock retention unit, Thermo’s peer segment has achieved a similar revenue than half of the SKUs, and especially in LSS, and optimizes the portfolio by optimizing the purchases to improve inventory turns, wastes and margins.
It is another way to optimize the portfolio of non -core assets. For BPS, some facilities work during periods of extended deduction and limit growth. For LSS, the sub -scale facilities in smaller geographies can be more valuable for an opponent, and the same applies to some assets purchased under the above -mentioned purchasing madness of Avantor.
On the cost of cost discipline, Avantor’s poor merger and low valuation and low valuation, scorpion merger and purchasing opportunities, and the company is on the way to reduce leverages below 3x, the market is concerned about this costly M&A strategy. The motor argues that free cash flow should be allocated equally to share reputation and debt reduction.
In addition, executive compensation is also a source of concern. In 2024, despite the decrease of organic revenue by 2% and 7% of the stock price, the CEO of the Board Michael Stubblefield gave 110% of its target annual bonus and underlined the need to align these management incentives with shareholders.
The motor believes that all these changes will be applied with the best comprehensive wooden refreshment. Probably, President Jonathan Peacock, which aims to replace the members of the Board of Directors, who aims to replace the destruction of value, should indicate the beginning of a new section. The engine believes that if these changes are applied properly, the Avantor shares will be between 22 and 26 dollars per share by the end of 2027.
As a secondary option, the engine recommends that if an independent way seems valid, the board should consider selling the entire company or dividing LSS and BPS into separate assets.
When Avantor now bought the VWR, the core of the LSS business, it was worth 12x EBITDA or $ 6.5 billion and traded in the 17x Ebitda median. None of the values of these businesses do not correspond to what Avantor is traded in about 8x EBITDA, and a strategic path is the best way to unlock this value on a basis. If this was the case, it is likely that it would be both a special and strategic interest. The new Mountain Capital had previously had the avantor before his public offering and still remains about 2% position. Strategies like Ingersoll would also be interested in a significant discount on their once. The engine believes that Avantor can sell between $ 17 and 19 dollars per share.
In general, the engine not only a major change in the Avantor, but also makes it difficult for a wide range of many ways. While some of these changes are already going on: a new CEO will start next week and the management announced an attempt to reduce a cost of $ 400 million, where the required exchange volume is not likely to take place with 2027 estimated.
The motor plan includes strengthening of the executive, vaccination of cost discipline culture, improving capital allocation, evaluating the company’s portfolio, aligning and aligning the executive compensation and renewing the Board. The plan of the engine is the right one, but this is something that has been in the decline of the upper line and business margins since 2022, and the renewal of a board renewal, decreasing income and business margins, and many of which cannot be done simultaneously, especially the director is something that cannot be nominated. Usually it is not a change from a friendly settlement.
Ken Squire is the founder and president of the 13D Monitor, a corporate research service on shareholder activism and is the founder and portfolio manager of the 13D Activist Fund, an investment fund investing in the investment portfolio of the activist 13D. Viasat belongs to the fund.
